Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits
byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini
Updated on: December 18,2024
0

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits
byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini
Updated on:December 18,2024
0
